Medicaid Bulletin

Medicaid Bulletin Monthly Digest

Medicaid Bulletin Archive

Articles beginning January 2018 are available in the blog format.

How to best serve beneficiaries who have not received nursing services for 30 consecutive days.

This bulletin replaces the NC Medicaid Respiratory Syncytial Virus (RSV) Guidelines for 2023-2024 - Revised published Nov. 3, 2023.

The American Medical Association has added new CPT codes, deleted others and changed the descriptions of some existing codes.

Effective with date of service Sept. 1, 2023, NC Medicaid covers talquetamab-tgvs injection, for subcutaneous use (Talvey).

Effective with date of service Aug. 15, 2023, the NC Medicaid programs cover elranatamab-bcmm injection, for subcutaneous use (Elrexfio).

Effective with date of service Aug. 19, 2023, NC Medicaid covers pozelimab-bbfg injection, for intravenous or subcutaneous use (Veopoz).

Effective with date of service Sept. 1, 2023, NC Medicaid Direct and NC Medicaid Managed Care cover cantharidin topical solution (Ycanth).

Effective with date of service Sept. 6, 2023, NC Medicaid Direct and NC Medicaid Managed Care cover avacincaptad pegol intravitreal solution (Izervay)

Effective with date of service Aug. 21, 2023, Medicaid covers aflibercept injection, for intravitreal use (Eylea HD)

The updated policy aims to minimize the impact of health plan accreditation on delegated care management entities